微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 47.72% | -0.52% | 10.57% | 12/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 43.16% | -6.29% | 12.09% | 19/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 38.5% | -16.53% | -20.32% | 23/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 48.33% | -5.06% | 0.74% | 8/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 47.97% | -4% | 4.15% | 8/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 46.06% | -3.31% | -0.16% | 12/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 46.13% | 0.81% | -9.37% | 12/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 50.9% | 22.69% | 1.86% | 6/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 49.97% | 12.23% | 4.9% | 9/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 47.64% | 25.75% | 4.1% | 10/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 45.76% | 41.56% | 10.3% | 14/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 41.49% | -11.62% | -6.82% | 27/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 44.52% | -10.71% | 17.53% | 19/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 37.88% | -23.03% | 17.19% | 32/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 32.33% | -8.09% | -31.14% | 34/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 46.94% | -10.56% | -5.86% | 19/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 49.87% | 6.46% | 1.33% | 9/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 49.21% | -8.15% | 39.93% | 14/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 35.17% | -28.94% | -32.99% | 22/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 52.49% | -15.84% | 12.05% | 13/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 46.84% | -24.6% | -12.58% | 12/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 53.58% | -12.84% | 8.26% | 8/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | 49.49% | -9.12% | -20.64% | 6/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 62.36% | 42.87% | 0.39% | 4/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 62.12% | 38.46% | 1.05% | 4/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 61.47% | 12.42% | 12.89% | 4/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 54.46% | -31.73% | 24.76% | 8/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 43.65% | -16.07% | -2.72% | 19/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 44.87% | -7.9% | -17.95% | 13/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 54.68% | 17.19% | -31.45% | 7/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 79.77% | 43.02% | 53.37% | 2/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 52.01% | 112.24% | 6.76% | 8/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 48.71% | 39.13% | 4.4% | 8/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 46.66% | -11.55% | -16.34% | 11/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 55.78% | 12.57% | 127.61% | 4/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 24.5% | -47.98% | -30.02% | 28/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 35.02% | -32.86% | -33.63% | 13/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 52.75% | -5.21% | 6.47% | 3/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 49.55% | -6.86% | 5.18% | 2/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |